Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Relevant update…moving forward

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Jul 24, 2023 8:52am

153 Views

Post# 35553963

RE:RE:RE:RE:Relevant update…moving forward

Agreed Noteable. Imagine this investor suggesting that we SH, who have played pivotal roles in keeping the company afloat for all these years aren't owed anything!?! The shortsightedness and ignorance is palpable. This investor has also taken to overusing the word myopic...I think it's just a desperate attempt to counter growing evidence that he or she is just under educated. My opinion. GL all!

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario